{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T09:59:48Z","timestamp":1795168788640,"version":"4.10.3"},"reference-count":45,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2010,10,12]],"date-time":"2010-10-12T00:00:00Z","timestamp":1286841600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Veterinary Dermatology"],"published-print":{"date-parts":[[2011,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Antimicrobials effective against meticillin\u2010resistant staphylococci are limited. Mupirocin is a topical antimicrobial used to treat bacterial skin infections. Novobiocin is an oral antimicrobial approved for treatment of staphylococcal upper respiratory infections in dogs. This study reports the <jats:italic>in vitro<\/jats:italic> activity of mupirocin and novobiocin on meticillin\u2010susceptible (MSS) and resistant staphylococci (MRS) from healthy dogs and dogs with superficial pyoderma. Staphylococci were isolated from skin swabs at four sites on healthy dogs and from lesions on dogs with superficial pyoderma. Staphylococci were identified by morphology and by catalase and coagulase testing. Speciation and susceptibility testing were performed by the Dade Microscan (W. Sacramento, CA, USA). Meticillin resistance was confirmed by an oxacillin screen plate. Novobiocin and mupirocin susceptibilities were tested by disc diffusion. Staphylococci were cultured from 61 healthy dogs (17 MRS and 44 MSS) and 30 dogs with pyoderma (15 MRS and 15 MSS), with higher proportions of MRS isolates in dogs with pyoderma (<jats:italic>P<\/jats:italic>\u2003=\u20030.038; \u03c7<jats:sup>2<\/jats:sup> test). For mupirocin, 79.5% (35 of 44) MSS and 82.3% (14 of 17) MRS isolates from healthy dogs, and 100% (15 of 15) MSS and 86.6% (13 of 15) MRS isolates from dogs with pyoderma were susceptible (MSS, <jats:italic>P<\/jats:italic>\u2003=\u20030.094; MRS, <jats:italic>P<\/jats:italic>\u2003=\u20031.0; Fisher\u2019s exact test). For novobiocin, 95.4% (42 of 44) MSS and 52.9% (nine of 17) MRS isolates from healthy dogs and 93.3% (14 of 15) MSS and 80% (12 of 15) MRS isolates from dogs with pyoderma were susceptible (MSS, <jats:italic>P<\/jats:italic>\u2003=\u20031.0; MRS, <jats:italic>P<\/jats:italic>\u2003=\u20030.148; Fisher\u2019s exact test).<\/jats:p>","DOI":"10.1111\/j.1365-3164.2010.00921.x","type":"journal-article","created":{"date-parts":[[2010,10,12]],"date-time":"2010-10-12T22:08:13Z","timestamp":1286921293000},"page":"88-94","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["<i>In vitro<\/i> susceptibility testing of meticillin\u2010resistant and meticillin\u2010susceptible staphylococci to mupirocin and novobiocin"],"prefix":"10.1111","volume":"22","author":[{"given":"Kristen S.","family":"Fulham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen L.","family":"Lemarie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giselle","family":"Hosgood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hani L. N.","family":"Dick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,10,12]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.5326\/0410150"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-7216-7618-0.50008-0"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1099\/00207713-26-4-401"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01915-08"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1128\/JB.01150-07"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vetmic.2008.06.002"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00360-07"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vetmic.2009.01.039"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1574-6976.2007.00095.x"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1128\/JB.00822-09"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtbi.2008.05.037"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/24.Supplement_1.S74"},{"key":"e_1_2_5_14_2","first-page":"1","volume-title":"Freedom of Information","author":"New Animal Drug Application (Bactoderm\u00ae)","year":"1998"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-3164.1999.00185.x"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkn398"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkp159"},{"key":"e_1_2_5_18_2","first-page":"47","volume-title":"Proceedings of an International Symposium","author":"Casewell MW","year":"1985"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.37.12.2736"},{"key":"e_1_2_5_20_2","first-page":"567","volume-title":"Plumb\u2019s Veterinary Drug Handbook","author":"Plumb DC","year":"2005"},{"key":"e_1_2_5_21_2","first-page":"84","article-title":"Current therapeutics","volume":"179","author":"Finland M","year":"1957","journal-title":"The Practitioner"},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01235-07"},{"key":"e_1_2_5_23_2","first-page":"694","volume-title":"The Merck Veterinary Manual","author":"Kahn C","year":"2005"},{"key":"e_1_2_5_24_2","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1128\/jcm.28.3.608-609.1990","article-title":"Interpretive criteria for disk diffusion susceptibility testing of mupirocin, a topical antibiotic","volume":"28","author":"Fuchs PC","year":"1990","journal-title":"Journal of Clinical Microbiology"},{"key":"e_1_2_5_25_2","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1128\/AAC.41.5.1137","article-title":"Interpretive criteria of testing of susceptibility of staphylococci to mupirocin","volume":"41","author":"Finlay JE","year":"1997","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"e_1_2_5_26_2","doi-asserted-by":"publisher","DOI":"10.1099\/jmm.0.46965-0"},{"key":"e_1_2_5_27_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkn345"},{"key":"e_1_2_5_28_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3164.2007.00604.x"},{"key":"e_1_2_5_29_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkh332"},{"key":"e_1_2_5_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vetmic.2005.06.003"},{"key":"e_1_2_5_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vetmic.2007.06.015"},{"key":"e_1_2_5_32_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid1112.050241"},{"key":"e_1_2_5_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vetmic.2006.12.007"},{"key":"e_1_2_5_34_2","doi-asserted-by":"publisher","DOI":"10.1128\/JB.183.8.2417-2424.2001"},{"key":"e_1_2_5_35_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01024-08"},{"key":"e_1_2_5_36_2","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-200203000-00025"},{"key":"e_1_2_5_37_2","doi-asserted-by":"crossref","first-page":"4262","DOI":"10.1128\/JCM.38.11.4262-4263.2000","article-title":"Frequency of isolation of Staphylococcus lugdunensis among staphylococcal isolates causing endocarditis: a 20\u2010year experience","volume":"38","author":"Patel R","year":"2000","journal-title":"Journal of Clinical Microbiology"},{"key":"e_1_2_5_38_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1699-0463.1993.tb00183.x"},{"key":"e_1_2_5_39_2","doi-asserted-by":"publisher","DOI":"10.1086\/341304"},{"key":"e_1_2_5_40_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.41.4.1404-1409.2003"},{"key":"e_1_2_5_41_2","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1128\/jcm.29.3.419-421.1991","article-title":"Occurrence of Staphylococcus lugdunensis in consecutive clinical cultures and relationship of isolation to infection","volume":"29","author":"Herchline TE","year":"1991","journal-title":"Journal of Clinical Microbiology"},{"key":"e_1_2_5_42_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01974001"},{"key":"e_1_2_5_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vetmic.2005.09.011"},{"key":"e_1_2_5_44_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/41.1.11"},{"key":"e_1_2_5_45_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.50.4.1136-1142.2006"},{"key":"e_1_2_5_46_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/15.4.435"}],"container-title":["Veterinary Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-3164.2010.00921.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-3164.2010.00921.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T12:35:44Z","timestamp":1697286944000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-3164.2010.00921.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10,12]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["10.1111\/j.1365-3164.2010.00921.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-3164.2010.00921.x","archive":["Portico"],"relation":{},"ISSN":["0959-4493","1365-3164"],"issn-type":[{"value":"0959-4493","type":"print"},{"value":"1365-3164","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,10,12]]},"assertion":[{"value":"2010-10-12","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}